Related Research Articles
David Da-i Ho is a Taiwanese American AIDS researcher, physician and virologist who has made a number of scientific contributions to the understanding and treatment of HIV infection. He championed for combination anti-retroviral therapy instead of single therapy, which turned HIV from an absolute terminal disease into a chronic disease.
Zidovudine (ZDV), also known as azidothymidine (AZT), was the first antiretroviral medication used to prevent and treat HIV/AIDS. It is generally recommended for use in combination with other antiretrovirals. It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure. It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine. It can be used by mouth or by slow injection into a vein.
Jerome Phillip Horwitz was an American scientist; his affiliations included the Barbara Ann Karmanos Cancer Institute, the Wayne State University School of Medicine and the Michigan Cancer Foundation.
Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine, dolutegravir, and abacavir. Lamivudine may be included as part of post-exposure prevention in those who have been potentially exposed to HIV. Lamivudine is taken by mouth as a liquid or tablet.
Nevirapine (NVP), sold under the brand name Viramune among others, is a medication used to treat and prevent HIV/AIDS, specifically HIV-1. It is generally recommended for use with other antiretroviral medications. It may be used to prevent mother to child spread during birth but is not recommended following other exposures. It is taken by mouth.
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a nonprofit organization dedicated to preventing pediatric HIV infection and eliminating pediatric AIDS through research, advocacy, and prevention and treatment programs. Founded in 1988, the organization works in 12 countries around the world.
The Miller School of Medicine, officially Leonard M. Miller School of Medicine, is the University of Miami's graduate medical school in Miami, Florida. Founded in 1952, it is the oldest medical school in the state of Florida.
Robert Yarchoan is a medical researcher who played an important role in the development of the first effective drugs for AIDS. He is the Chief of the HIV and AIDS Malignancy Branch in the NCI and also coordinates HIV/AIDS malignancy research throughout the NCI as director of the Office of HIV and AIDS Malignancy (OHAM).
Joseph Adolph Sonnabend was a South African physician, scientist and HIV/AIDS researcher, notable for pioneering community-based research, the propagation of safe sex to prevent infection, and an early multifactorial model of AIDS.
Krisana Kraisintu is a Thai professor and pharmacist, as known as the "Gypsy pharmacist". She was pharmaceutical consultant in the local production and increased access to life-saving medicines in Africa, in particular, malaria and HIV/AIDS-related drug production.
Agnes Binagwaho is a Rwandan Politician, pediatrician, co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She has served the health sector in various high-level government positions. She resides in Kigali.
Julio S. G. Montaner, is an Argentine-born Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART, a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.
Mary Jane Rotheram-Borus is a licensed clinical psychologist and professor with the University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences. Rotheram is the professor-in-residence in the Semel Institute for Neuroscience and Human Behavior. She is the Director of the Global Center for Children and Families at UCLA and the former director of the Center for HIV Identification, Prevention, and Treatment Services.
Janet L. Mitchell was an American physician known for her advances in perinatal HIV/AIDS treatment. During the early days of the AIDS epidemic in the U.S. Mitchell developed protocols for health treatment of pregnant women who were HIV positive or at risk for developing AIDS. She advocated against mandatory testing and testifying before Congress, she advocated in favor of an inclusive approach to health care and social services. One of her innovations derived from a study that saw a 70% decrease in HIV transmission to babies when AZT was administered to their mothers during the pregnancy.
Deborah Leah Birx is an American physician and diplomat who served as the White House Coronavirus Response Coordinator under President Donald J. Trump from 2020 to 2021. Birx specializes in HIV/AIDS immunology, vaccine research, and global health. Starting in 2014, she oversaw the implementation of the President's Emergency Plan for AIDS Relief (PEPFAR) program to support HIV/AIDS treatment and prevention programs in 65 countries. From 2014-2020, Birx was the United States global AIDS coordinator for presidents Barack Obama and Donald J. Trump and served as the United States special representative for global health diplomacy between 2015 and 2021. Birx was part of the White House Coronavirus Task Force from February 2020 to January 2021. In March 2021, Birx joined ActivePure Technology as Chief Medical and Science Advisor.
Adaora Alise Adimora was an American doctor and academic. She was the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centered on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.
Diane Havlir is an American physician who is a Professor of Medicine and Chief of the HIV/AIDS Division at the University of California, San Francisco. Her research considers novel therapeutic strategies to improve the lives of people with HIV and to support public health initiatives in East Africa. She was elected to the National Academy of Medicine in 2019.
Monica Gandhi is an American physician and professor. She teaches medicine at the University of California, San Francisco (UCSF) and is director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86. Her research considers HIV prevalence in women, as well as HIV treatment and prevention. She has been noted as a critic of some aspects of the COVID-19 lockdowns in the US.
Prasanna Nair is an Indian-born doctor working in the United States. She works in primary health care with a specialty in pediatric endocrinology
Ligia Peralta is a Dominican-born doctor of pediatrics and adolescent medicine in Maryland. Her research focuses on HIV and the transmission of HIV in adolescents, specifically those from under-served communities.
References
- 1 2 "Margaret Fischl". 'Cane Talks. University of Miami . Retrieved July 4, 2021.
- ↑ "Margaret Fischl, M.D." University of Miami Health Systems. Retrieved July 4, 2021.
- 1 2 Fischl, Margaret (May 30, 2006). "Interview: Margaret Fischl". Frontline (Interview). PBS . Retrieved July 4, 2021.
- 1 2 Burkett, Elinor (September 23, 1990). "THE QUEEN OF AZT: To Our Only Weapon Against AIDS, Margaret Fischl Owes Everything: Her Fame and Her Infamy". Miami Herald . Archived from the original on August 18, 2006.
- ↑ Walsh, Sara-Megan (December 20, 2020). "Watson Clinic doctor opens post-COVID clinic in Lakeland". The Ledger . Retrieved July 4, 2021.
- ↑ "Dr. Margaret A. Fischl MD". U.S. News & World Report . Retrieved July 4, 2021.
- 1 2 Park, Alice (March 19, 2017). "The Story Behind the First AIDS Drug". Time . Retrieved July 4, 2021.
- ↑ Laing, Richard; Waning, Brenda; Gray, Andy; Ford, Nathan; Hoen, Ellen 't (2003). "25 years of the WHO essential medicines lists: progress and challenges". The Lancet . 361 (9370): 1723–1729. doi:10.1016/S0140-6736(03)13375-2. hdl: 10144/28005 . PMID 12767751. S2CID 12172286.
| International | |
|---|---|
| National | |
| Academics | |
  | This biography of an American academic is a stub. You can help Wikipedia by expanding it. |
  | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |